Cocaine and β-Blockers: Should the Controversy Continue?

Annals of Emergency Medicine

Volumn 51, Issue 2, 2008, Pages 127-129

  Hoffman, Robert S ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLONIDINE; COCAINE; ESMOLOL; LABETALOL; PROPRANOLOL;

ACUTE CORONARY SYNDROME; ACUTE TOXICITY; ADRENERGIC RECEPTOR BLOCKING; ADRENERGIC SYSTEM; ANIMAL EXPERIMENT; BLOOD PRESSURE; CARDIOGENIC SHOCK; COCAINE DEPENDENCE; COOLING; CRITICALLY ILL PATIENT; DEATH; DIASTOLIC BLOOD PRESSURE; DISEASE COURSE; DISEASE EXACERBATION; DRUG CONTRAINDICATION; DRUG INDICATION; DRUG INTOXICATION; DYSPNEA; EDITORIAL; EMERGENCY TREATMENT; HEADACHE; HEART ARRHYTHMIA; HEART CATHETERIZATION; HEART INFARCTION; HUMAN; HYPERPYREXIA; HYPERTENSION; HYPERTHERMIA; HYPOTENSION; INCIDENCE; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MEDICAL DECISION MAKING; MORTALITY; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PULSE RATE; RESTLESSNESS; RISK ASSESSMENT; SEDATION; SEIZURE; SIDE EFFECT; SYNDROME DELINEATION; TACHYCARDIA; TELEMETRY;

ADRENERGIC BETA-ANTAGONISTS; COCAINE-RELATED DISORDERS; HUMANS; MYOCARDIAL INFARCTION; RISK ASSESSMENT;

EID: 38149070838     PISSN: 01960644     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.annemergmed.2007.08.011     Document Type: Editorial

References (31)

1. Rappolt R.T., Gay G., Inaba D.S., et al. Propranolol in cocaine toxicity. Lancet 2 (1976) 640-641
2. Rappolt R.T., Gay G.R., and Inaba D.S. Propranolol: a specific antagonist to cocaine. Clin Toxicol 10 (1977) 265-271
3. Rappolt Sr. R.T., Gay G., Inaba D.S., et al. Use of Inderal (propranolol-Ayerst) in I-a (early stimulative) and I-b (advanced stimulative) classification of cocaine and other sympathomimetic reactions. Clin Toxicol 13 (1978) 325-332
4. Guinn M.M., Bedford J.A., and Wilson M.C. Antagonism of intravenous cocaine lethality in nonhuman primates. Clin Toxicol 16 (1980) 499-508
5. Catravas J.D., and Waters I.W. Acute cocaine intoxication in the conscious dog: studies on the mechanism of lethality. J Pharmacol Exp Ther 217 (1981) 350-356
6. Goldfrank L.R., and Hoffman R.S. The cardiovascular effects of cocaine: update 1992. Acute Cocaine Intoxication: Current Methods and Treatment. National Institute on Drug Abuse Research Monograph Series 123 (1993) 70-109
7. Sand I.C., Brody S.L., Wrenn K.D., et al. Experience with esmolol for the treatment of cocaine-associated cardiovascular complications. Am J Emerg Med 9 (1991) 161-163
8. Dusenberry S.J., Hicks M.J., and Mariani P.J. Labetalol treatment of cocaine toxicity. Ann Emerg Med 16 (1987) 235
9. Gay G.R., and Loper K.A. The use of labetalol in the management of cocaine crisis. Ann Emerg Med 17 (1988) 282-283
10. Gay G.R., and Loper K.A. Control of cocaine-induced hypertension with labetalol. Anesth Analg 67 (1988) 92
11. Derlet R.W., and Albertson T.E. Acute cocaine toxicity: antagonism by agents interacting with adrenoceptors. Pharmacol Biochem Behav 36 (1990) 225-231
12. Kenny D., Pagel P.S., and Warltier D.C. Attenuation of the systemic and coronary hemodynamic effects of cocaine in conscious dogs: propranolol versus labetalol. Basic Res Cardiol 87 (1992) 465-477
13. Trouve R., and Nahas G.G. Antidotes to lethal cocaine toxicity in the rat. Arch Int Pharmacodyn Ther 305 (1990) 197-207
14. Smith M., Garner D., and Niemann J.T. Pharmacologic interventions after an LD50 cocaine insult in a chronically instrumented rat model: are beta-blockers contraindicated?. Ann Emerg Med 20 (1991) 768-771
15. National Quality Measures Clearinghouse. Acute myocardial infarction: percent of patients without beta blocker contraindications who received a beta blocker within 24 hours after hospital arrival. http://www.qualitymeasures.ahrq.gov/summary/summary.aspx?doc_id=6054 Accessed July 4, 2007
16. Joint Commission on Accreditation of Healthcare Organizations. Beta blockers for acute myocardial infarction. http://www.jointcommission.org/NR/rdonlyres/AB92B013-B9A7-48AC-8AC6-759410D6E791/0/COMMITBetaBlockerFACTSheet.pdf Accessed July 4, 2007
17. Chen Z.M., Pan H.C., Chen Y.P., et al., COMMIT (ClOpidogrel and Metoprolol in Myocardial Infarction Trial) Collaborative Group. Early intravenous then oral metoprolol in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial. Lancet 366 (2005) 1622-1632
18. Hollander J.E., and Hoffman R.S. Cocaine-induced myocardial infarction: an analysis and review of the literature. J Emerg Med 10 (1992) 169-177
19. Hollander J.E., Hoffman R.S., Gennis P., et al. Prospective multicenter evaluation of cocaine-associated chest pain. Cocaine Associated Chest Pain (COCHPA) Study Group. Acad Emerg Med 1 (1994) 330-339
20. Hollander J.E., Hoffman R.S., Burstein J.L., et al. Cocaine-associated myocardial infarction. Mortality and complications. Cocaine-Associated Myocardial Infarction Study Group. Arch Intern Med 155 (1995) 1081-1086
21. Weber J.E., Chudnofsky C.R., Boczar M., et al. Cocaine-associated chest pain: how common is myocardial infarction?. Acad Emerg Med 7 (2000) 873-877
22. Hollander J.E., Hoffman R.S., Gennis P., et al. Cocaine-associated chest pain: one-year follow-up. Acad Emerg Med 2 (1995) 179-184
23. Lange R.A., Cigarroa R.G., Flores E.D., et al. Potentiation of cocaine-induced coronary vasoconstriction by beta-adrenergic blockade. Ann Intern Med 112 (1990) 897-903
24. Lange R.A., Cigarroa R.G., Yancy Jr. C.W., et al. Cocaine-induced coronary-artery vasoconstriction. N Engl J Med 321 (1989) 1557-1562
25. Boehrer J.D., Moliterno D.J., Willard J.E., et al. Influence of labetalol on cocaine-induced coronary vasoconstriction in humans. Am J Med 94 (1993) 608-610
26. Albertson T.E., Dawson A., de Latorre F., et al., American Heart Association, International Liaison Committee on Resuscitation. TOX-ACLS: toxicologic-oriented advanced cardiac life support. Ann Emerg Med 37 4 suppl (2001) S78-S90
27. Dattilo P.B., Hailpern S.M., Fearon K., et al. β-blockers are associated with reduced risk of myocardial infarction after cocaine use. Ann Emerg Med 51 (2008) 117-125
28. Merigian K.S., Park L.J., Leeper K.V., et al. Adrenergic crisis from crack cocaine ingestion: report of five cases. J Emerg Med 12 (1994) 485-490
29. Leikin J.B. Cocaine and beta-adrenergic blockers: a remarriage after a decade-long divorce?. Crit Care Med 27 (1999) 688-689
30. Weiss R.D., and Gawin F.H. Protracted elimination of cocaine metabolites in long-term high-dose cocaine abusers. Am J Med 85 (1988) 879-880
31. Fareed F.N., Chan G.M., and Hoffman R.S. Death temporally related to the use of a beta adrenergic receptor antagonist in cocaine associated myocardial infarction. J Med Toxicol 3 (2007) 169-172